Neuroactive steroids, compositions, and uses thereof
Number of patents in Portfolio can not be more than 2000
United States of America
Stats
-
Oct 29, 2024
Grant Date -
Jun 22, 2023
app pub date -
Mar 29, 2022
filing date -
Mar 29, 2022
priority date (Note) -
In Force
status (Latency Note)
Importance
Loading Importance Indicators... 
Abstract
Compounds are provided according to Formula (I) and pharmaceutically acceptable salts thereof, wherein Z is a group of the formula (i), (ii), (iii), (iv), or (v), and wherein L1, L2, L3, X1, X2, Y, Rz4, Rz5, Rz6, n, R1, R2, R3a, R3b, R4a, R4b, R6a, R6b, R7a, R7b, R11a, R11b, R14, R17, R19, R20, R23a, R23b, and R24 are as defined herein, and pharmaceutical compositions thereof. Compounds of the present invention are contemplated useful for the prevention and treatment of a variety of CNS-related conditions in mammals.
First Claim
Other Claims data not available
Family
Loading Family data...
International Classification(s)
- 2022 Application Filing Year
- C07J Class
- 111 Applications Filed
- 18 Patents Issued To-Date
- 16.22 % Issued To-Date
Cited Art Landscape
Patent Citation Ranking
- 0 Citation Count
- C07J Class
- 0 % this patent is cited more than
- 1 Age
Maintenance Fees
| Fee | Large entity fee | small entity fee | micro entity fee | due date |
|---|---|---|---|---|
| 3.5 Year Payment | $1600.00 | $800.00 | $400.00 | Apr 29, 2028 |
| 7.5 Year Payment | $3600.00 | $1800.00 | $900.00 | Apr 29, 2032 |
| 11.5 Year Payment | $7400.00 | $3700.00 | $1850.00 | Apr 29, 2036 |